Associations Between Both HIV and Metabolic Comorbidity and Self-Reported Mpox Among Men Who Have Sex With Men:...

Men who have sex with men (MSM) face a disproportionately high risk of mpox infection, and China has recently experienced a rapid increase in the reported cases. This population also has a high prevalence of HIV, which has been identified as a critical factor in understanding the vulnerability to mpox. In addition, metabolic diseases frequently co-occur with HIV and share immunometabolic pathways, raising concerns that they may interact to confer additional risk of mpox infection.

This study examines the potential interaction between HIV and metabolic comorbidity in relation to self-reported mpox among MSM in China.

A cross-sectional study was conducted among MSM aged 18 to 76 years from October 2023 to March 2024 in 6 representative provincial regions of China. Participants completed an anonymous questionnaire on HIV infection, metabolic diseases (hypertension, diabetes mellitus, and hyperlipidemia), and mpox infection. Metabolic comorbidity was defined as the presence of more than one of these conditions. Logistic regression models were used to examine associations, and additive and multiplicative interactions between HIV and metabolic comorbidity were assessed.

Of the 2403 MSM, 56 (2.33%) reported mpox, 199 (8.28%) reported HIV, and 325 (13.52%) reported at least one metabolic comorbidity (hypertension, diabetes, or hyperlipidemia). Both HIV (odds ratio [OR] 4.81, 95% CI 2.29-9.64) and metabolic comorbidity (OR 2.62, 95% CI 1.27-5.14) were associated with higher odds of mpox infection. A dose-response relationship was observed, with the odds of mpox increasing with the number of conditions (per-condition trend: OR 3.03, 95% CI 1.86-4.83). While multiplicative interaction was not statistically significant (interaction term=2.98, 95% CI 0.68-13.70; P=.15), additive interaction metrics suggested a possible excess association (relative excess risk due to interaction=10.80, 95% CI 1.21-37.52; attributable proportion due to interaction=0.74, 95% CI 0.07-0.87; synergy index=4.99, 95% CI 1.19-20.86). Compared to the participants without HIV or metabolic comorbidity, those with HIV and metabolic comorbidity had higher odds of mpox infection (OR 14.51, 95% CI 4.83-40.70).

This study suggests that HIV and metabolic comorbidity were each associated with higher odds of self-reported mpox, and exploratory analyses indicated a possible additive interaction. Given the reliance on self-reported diagnoses and the cross-sectional design, the findings should be interpreted with caution due to reporting bias and reverse causation. Further studies are needed to confirm these associations and better understand the comprehensive health needs of MSM with co-occurring conditions.